Using Virtual Reality to Help Caregivers and Improve Quality of Life for People with Dementia

VR&R: Providing Respite to Caregivers by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy

Not applicable Interventional University Health Network, Toronto · NCT05867641

This study is testing if using virtual reality at home can help caregivers feel less stressed and improve the quality of life for people with dementia.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment50 (estimated)
Ages65 Years and up
SexAll
SponsorUniversity Health Network, Toronto Academic / other
Locations7 sites (Oakville, Ontario and 6 other locations)
Trial IDNCT05867641 on ClinicalTrials.gov

What this trial studies

This interventional trial explores how immersive Virtual Reality (VR) therapy can be utilized at home by individuals with dementia, with support from their informal caregivers. The study aims to determine if VR therapy can provide respite for caregivers, reduce their feelings of burden, and improve their well-being. Additionally, it investigates whether VR therapy can effectively manage behavioral and psychological symptoms in individuals with dementia and enhance their quality of life. Participants will engage in VR therapy sessions at home for four weeks, using different VR mediums to assess their effectiveness.

Who should consider this trial

Good fit: Ideal candidates include individuals aged 65 and older diagnosed with dementia who live at home with a family caregiver.

Not a fit: Patients with conditions that contraindicate the use of VR headsets, such as seizures, severe visual impairments, or certain medical devices, may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly alleviate caregiver burden and enhance the quality of life for both caregivers and individuals with dementia.

How similar studies have performed: Other studies have indicated that VR therapy is a promising non-pharmacological intervention for dementia, suggesting potential success for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria: People with dementia

* Individuals who are 65 years of age or older
* Individuals living at home with a family caregiver
* Individuals diagnosed with dementia

Exclusion Criteria:

* Individuals with open wounds on face (sutured lacerations exempted)
* Individuals with a history of seizures or epilepsy
* Individuals with a pacemaker
* Individuals with head trauma or stroke leading to their current admission
* Individuals with cervical conditions or injuries that would make it unsafe for them to use the VR headset
* Individuals who identify as being legally blind
* Individuals with alcohol related dementia/ Korsakoff syndrome.
* Individuals who have a Public Guardian and Trustee (PGT) as Substitute Decision Maker (SDM)
* Individuals who cannot speak and understand English

Caregiver inclusion criteria:

* Individuals who identify as a primary caregiver for the PwD
* Individuals who have access to the internet through a device (computer, tablet, or mobile phone) that can be used during the study

Caregiver exclusion criteria:

* Individuals who cannot speak and understand English
* Individuals who are cognitively unable to provide informed consent for themselves
* Identify as legally blind

Where this trial is running

Oakville, Ontario and 6 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions DementiaNon-pharmacologicalCaregiver RespiteVirtual RealityHome Based CareQuality of LifeBehavioral and psychological symptoms of dementiaMood
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.